compounded semaglutide being discontinued GLP-1 - & Tirzepatide Navigating changes in access to

The drug may no longer be manufactured or available in the U.S

Diabetes & Prediabetes Management : Clinical strategies to manage blood sugar and improve A1c markers

(2002), Bupropion SR Enhances Weight Loss: A 48-Week Double-Blind, Placebo- Controlled Trial

To minimize the risk of these reactions, its important to rotate the injection site after each shot

The SURPASS-5 study assessed the efficacy and safety of an injectable combination therapy combining tirzepatide with insulin glargine (75)

You might NOT be able to take GLP-1 if you have a history of pancreatitis, kidney disease/kidney insufficiency, Stomach problems, diabetes (must be approved from endocrinologist) or gall bladder disease